Navigation Links
U-M Medical School and MedImmune join forces to accelerate search for new therapies
Date:11/21/2011

Leaders from the University of Michigan Medical School and MedImmune, the global biologics arm of AstraZeneca, have signed a new agreement to work together on a broad range of projects.

The three-year strategic collaboration will bring scientists from one of the nation's top medical research institutions together with scientists from one of the world's leading developers of biologic therapies.

UMMS and MedImmune scientists will cooperate on studies that aim to translate scientific discoveries from the laboratory into new candidates for treating cancer, heart disease, digestive disease, lung disease and diseases caused by inflammation.

This type of translational and pre-clinical research is designed to identify and confirm the specific molecules and genes involved in causing disease, and potential molecules and cell-based therapies to treat or prevent them.

"We are thrilled to partner with MedImmune in a collaborative and creative way to bring new innovations to market," says Steven Kunkel, Ph.D., senior associate dean for research at the U-M Medical School and Endowed Professor of Pathology Research. "This strategic partnership, one of the first of its kind for our institution, speaks to our desire to collaborate with industry to accelerate translation of U-M's cutting-edge research to impact patients."

The new agreement goes beyond the traditional type of academic-industry research relationship, in which companies fund projects such as clinical trials, or license patents on discoveries made by university scientists and develop them on their own. In this new type of agreement, scientists from medical schools and industry collaborate closely on projects while also preserving academic freedom, research integrity and both sides' rights to intellectual property for discoveries.

"This new horizon in industry-academic partnership ultimately benefits patients, who demand new and better options for treating disea
'/>"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. New smart material could help tap medical potential of tissue-penetrating light
2. CDC and Prevention awards Mayo Clinic an international medical education grant
3. New international health survey of sicker adults: Those with a medical home fare better
4. Jefferson is first academic medical center to offer FDA-approved BRAF mutation for melanoma patients
5. University Hospitals Case Medical Center neurosurgeons champion brain bypass in select patients
6. Teen Pot Use Unaffected by Medical Marijuana Law: Study
7. Report calls for creation of a biomedical research and patient data network for more accurate classification of diseases, move toward precision medicine
8. Diagnostic physicians at increased risk for medical malpractice claims due to communication failures
9. Medical researchers ID potential new drug target that could stop debilitating effects of MS
10. Ghost Writing Persists in Major Medical Journals
11. Harvard Medical School and EPFL launch program targeting neurological disabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Cheap Concert Tickets announces that ... 2013 at stadiums throughout North America. This well known ... McCartney concert tickets to help McCartney fans see Sir Paul ... Tickets, states that she is also offering the customer appreciation ... Being a baby boomer, she is also a huge McCartney ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- The sensation of ... be traced back to a small molecule released in ... mice. Researchers say this molecule, known as ... through the central nervous system. Ultimately, this signal is ... humans and mice are similar, the researchers concluded that ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) -- ... badly as methamphetamine or crack cocaine, a new study ... mouth, or ,coke mouth, it is startling to see ... the same," said Dr. Mohamed Bassiouny, a professor of ... in Philadelphia. Methamphetamine, crack cocaine and soda -- ...
(Date:5/23/2013)... Chinese and U.S. scientists have used virus isolated from ... to determine whether the virus could infect and be ... mammalian model in influenza research, and efficient transmission of ... how well the same process might occur in people. ... Institute of Allergy and Infectious Diseases, part of the ...
(Date:5/23/2013)... 23, 2013 Special Learning, Inc., ... educational resources for the autism, Down syndrome and ... opening its first global autism treatment center and ... August. This new world-class program is the first ... evidence-based practices to treat and deliver exceptional education ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Ferrets, pigs susceptible to H7N9 avian influenza virus 2Health News:Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines 2Health News:Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines 3
... SOUTH EASTON, Mass., March 10 Pressure,BioSciences, Inc. ... has moved its,corporate offices to 14 Norfolk Avenue ... accommodate the Company,s transition from an,early-stage, research and ... Schumacher, PBI,s Founder, President, and CEO,commented: "We now ...
... CT System Brings More Innovative Diagnostics to the ... ... March 10 Encouraged by the outstanding,marketing success of the worldwide ... ) announces the 510(k) market clearance of four,new applications aimed at ...
... bone damage and stunted growth , , MONDAY, March 10 ... may place pediatric patients at risk for bone damage ... new red flag concerns a signal transduction inhibitor (STI) ... medulloblastoma brain tumors by short-circuiting tumor growth on the ...
... University of Michigan Health System have found a key ... discovery that lends new insight into fibromyalgia, an often-baffling ... found, pain decreased when levels of the brain molecule ... which appears in the journal Arthritis and Rheumatism, could ...
... Donation Helps Provide Free Surgical Treatments for Children ... Operation Smile, a,worldwide children,s medical charity, today announced ... part of a ,sharing smiles, campaign,from Windows Live. ... physical,examinations and surgical treatment to children in 26 ...
... A study by the Woolcock Institute of Medical Research in ... very mild or well-controlled asthma, regular treatment with low dose ... , The study published in this months edition of Primary ... and compared the effects of inhaled corticosteroids (ICS) and placebo ...
Cached Medicine News:Health News:Pressure BioSciences, Inc. Announces Move to New Corporate Offices 2Health News:Siemens Introduces New Dual Energy Applications to SOMATOM Definition 2Health News:Siemens Introduces New Dual Energy Applications to SOMATOM Definition 3Health News:Siemens Introduces New Dual Energy Applications to SOMATOM Definition 4Health News:New Drug for Brain Cancer Too Dangerous for Pediatric Patients 2Health News:New Drug for Brain Cancer Too Dangerous for Pediatric Patients 3Health News:Pain in fibromyalgia is linked to changes in brain molecule 2Health News:Windows Live $500,000 Donation Commemorates Operation Smile's 25th Anniversary 2Health News:Treatment for mild asthma leads to improved lung function 2
(Date:5/23/2013)... 23, 2013  Omeros Corporation (NASDAQ: ... Drug Application (IND) to evaluate OMS824 in Huntington,s ... and Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase ... the brain linked to a wide range of ... schizophrenia. OMS824 has shown promising results in animal ...
(Date:5/23/2013)... 2013 SynCardia Systems, Inc. ( www.syncardia.com ), ... Canada and CE ( Europe ) approved ... Centre in Scotland , which boasts ... SynCardia temporary Total Artificial Heart powered by the ... Bodyworks Exhibition, one of the most advanced exhibitions of ...
(Date:5/23/2013)... May 23, 2013  PAREXEL International Corporation (NASDAQ: ... presenting at the Jefferies Healthcare Conference in New York.  ... and Chief Financial Officer, will be making a presentation ... on Monday, June 3, 2013. A live ... "Investors" section of PAREXEL,s website at www.PAREXEL.com ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3PAREXEL International To Present At Jefferies Healthcare Conference 2
... The U.S. Food and Drug Administration today approved ... to blood transfusions in patients with thalassemia, a genetic ... response to prior chelation therapy. (Logo: ... have excess iron in the body from the frequent ...
... Reata Pharmaceuticals, Inc. announced Friday a significant expansion ... program, bardoxolone methyl, and to continue advancing its earlier-stage ... executives: Paul Audhya, MD, as Vice ... Hilary Malone, Ph.D., as Vice President and Chief Regulatory ...
Cached Medicine Technology:FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body 2FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body 3Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors 2Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors 3
... The Hub Cap Limited ... to provide outstanding fixation and ... targeted solution for four corner ... the plate offers the kind ...
... cornerstones of the Acutrak family are the ... Together they are used primarily for secure ... upper extremity, but have been used for ... stabilized with these two systems have ranged ...
... decade KMI® revolutionized the wrist arthroplasty market ... Wrist System. We're at it again, with ... the Universal2. Like the original, the Universal2 ... live with debilitating arthritis. To date, we ...
A straight suture punch with 2.5 mm needle and 2/0 to #1 monofilament suture....
Medicine Products: